window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : January 20, 2026

  • News
  • About Us
Contact Us

Drug Delivery

  • Biologics & Biosimilars,Biotech,Drug Development,Oncology,Pharmaceuticals and therapeutics,Technology and platforms

    Bio‑Sourcing and Zerion Pharma collaborate on first oral HER2 monoclonal antibody

    Bio‑Sourcing and Zerion Pharma have joined forces to develop the [...]

    January 12, 2026
  • Drug Delivery & Formulation,Events and Conferences,Manufacturing,Packaging,Sustainability

    Pharmapack 2026 to return to Paris with focus on GLP-1 therapies and sustainable packaging

    Pharmapack will return to Paris in January 2026, with this [...]

    January 8, 2026
  • Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Research & Development,Technology and platforms

    Nanexa and Moderna sign licence and option agreement for Pharmashell drug delivery development

    Nanexa has entered into a licence and option agreement with [...]

    December 12, 2025
  • Biotech,Clinical Development,Drug Development,European biotech,Events and Conferences,Partnerships & Funding,Pharmaceuticals and therapeutics,Women in Pharma

    CPHI Frankfurt Pharma Awards 2025 finalists unveiled, spotlighting innovation, sustainability and industry leadership

    From synthetic biology to patient access, AI-powered formulation to sustainable [...]

    September 26, 2025
  • Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Technology and platforms

    Nanexa secures Japanese patent for PharmaShell technology

    Nanexa has received approval for a Japanese patent covering a [...]

    September 23, 2025
  • CDMOs & Manufacturing,Drug Delivery & Formulation,Pharmaceuticals and therapeutics

    SGD Pharma to acquire Alphial to expand tubular glass and vial manufacturing in Europe

    SGD Pharma has signed an agreement with Italian private equity [...]

    September 7, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Drug Delivery & Formulation,Partnerships & Funding,Technology and platforms

    LNP pioneer Pieter Cullis joins Hongene’s scientific advisory board

    Hongene has appointed leading lipid nanoparticle (LNP) researcher Pieter Cullis [...]

    August 5, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Drug Delivery & Formulation,Partnerships & Funding

    Stevanato Group secures €200 million to support global capacity expansion for drug delivery solutions

    Stevanato Group has secured €200 million in financing to support [...]

    July 30, 2025
  • Drug Delivery & Formulation,Precision medicine,Technology and platforms

    Pusan National University researchers develop UV-activated smart materials for reversible shape-shifting and fixing

    Researchers at Pusan National University in South Korea have created [...]

    July 16, 2025
  • CDMOs & Manufacturing,Drug Delivery & Formulation

    Inside Biosynth’s bold Berlin bet on bioconjugation

    The new cleanroom suite boosts GMP capabilities to support conjugated [...]

    July 3, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Cereno Scientific publishes first peer-reviewed data on HDAC inhibitor CS014 showing antithrombotic effects without bleeding risk
    Categories: Biotech, Clinical Development, Drug Development, European biotech, Hematology, Research & Development, Respiratory
  • SPT Labtech adds automated Twist Bioscience NGS library preparation workflows to firefly platform
    Categories: Data Management, Genomics and sequencing, Research & Development, Technology and platforms
  • Almirall to launch phase 3 LumiNE study of lebrikizumab in nummular eczema
    Categories: Clinical Trials, Dermatology, Drug Development, European biotech, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top